| For: | Privitera G, Pugliese D, Lopetuso LR, Scaldaferri F, Papa A, Rapaccini GL, Gasbarrini A, Armuzzi A. Orphan patients with inflammatory bowel disease - when we treat beyond evidence. World J Gastroenterol 2021; 27(47): 8047-8057 [PMID: 35068853 DOI: 10.3748/wjg.v27.i47.8047] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i47/8047.htm |
| Number | Citing Articles |
| 1 |
Daniela Pugliese, Giuseppe Privitera, Marcello Fiorani, Laura Parisio, Valentin Calvez, Alfredo Papa, Antonio Gasbarrini, Alessandro Armuzzi. Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab. Therapeutic Advances in Gastroenterology 2022; 15 doi: 10.1177/17562848221102283
|
| 2 |
Giuseppe Privitera, Mariangela Allocca, Luca Antonioli, Emma Calabrese, Flavio Caprioli, Fabiana Castiglione, Silvio Danese, Marco Daperno, Gabriele Dragoni, Massimo Claudio Fantini, Carla Felice, Gionata Fiorino, Ambrogio Orlando, Lorenzo Pradelli, Davide Ribaldone, Fernando Rizzello, Edoardo Savarino, Franco Scaldaferri, Alessandro Armuzzi. Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care. Autoimmunity Reviews 2026; : 104068 doi: 10.1016/j.autrev.2026.104068
|
| 3 |
Giuseppe Privitera, Cristina Bezzio, Arianna Dal Buono, Roberto Gabbiadini, Laura Loy, Luca Brandaleone, Giacomo Marcozzi, Giulia Migliorisi, Alessandro Armuzzi. How comparative studies can inform treatment decisions for Crohn’s disease. Expert Opinion on Biological Therapy 2024; 24(9): 955 doi: 10.1080/14712598.2024.2389985
|